Image of Efficacy and safety of COVID-19 vaccines in older people

LITERATURE

Efficacy and safety of COVID-19 vaccines in older people


Several vaccines against coronavirus disease 2019 (COVID-19) are on the cusp of regulatory approval. eir safety and efficacy
in older people is critical to their success. Even though care home residents and older people are likely to be amongst the first
to be vaccinated, these patient groups are usually excluded from clinical trials. Data from several Phase II trials have given
cause for optimism, with strong antibody responses and reassuring safety profiles but, with the exception of AstraZeneca’s
vaccine, recruited few older people.


Availability

REQJ4580-2Available

Detail Information

Series Title
-
Call Number
-
Publisher : .,
Collation
-
Language
English
ISBN/ISSN
-
Classification
NONE
Content Type
-
Media Type
-
Carrier Type
-
Edition
-
Subject(s)
Specific Detail Info
Age and Ageing 2020; 1–5
Statement of Responsibility

Other version/related

No other version available


File Attachment



Information


RECORD DETAIL


Back To Previous